128 related articles for article (PubMed ID: 17894001)
21. Tissue-associated autoantigens in rheumatoid arthritis. Tissue-antigens detected by autoantibodies in synovial fluid and sera of RA patients.
von Landenberg P; Schölmerich J
Clin Rev Allergy Immunol; 2000 Feb; 18(1):59-71. PubMed ID: 10907108
[No Abstract] [Full Text] [Related]
22. Characterization of Autoantigens Targeted by Anti-Citrullinated Protein Antibodies In Vivo: Prominent Role for Epitopes Derived from Histone 4 Proteins.
Meng X; Ezzati P; Smolik I; Bernstein CN; Hitchon CA; El-Gabalawy HS
PLoS One; 2016; 11(10):e0165501. PubMed ID: 27788229
[TBL] [Abstract][Full Text] [Related]
23. Ex vivo soft-laser treatment inhibits the synovial expression of vimentin and α-enolase, potential autoantigens in rheumatoid arthritis.
Bálint G; Barabás K; Zeitler Z; Bakos J; Kékesi KA; Pethes A; Nagy E; Lakatos T; Bálint PV; Szekanecz Z
Phys Ther; 2011 May; 91(5):665-74. PubMed ID: 21436364
[TBL] [Abstract][Full Text] [Related]
24. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin.
Masson-Bessière C; Sebbag M; Girbal-Neuhauser E; Nogueira L; Vincent C; Senshu T; Serre G
J Immunol; 2001 Mar; 166(6):4177-84. PubMed ID: 11238669
[TBL] [Abstract][Full Text] [Related]
25. Antibodies to synovial antigens in recent-onset rheumatoid arthritis.
McColl GJ; Cram DS; Harrison LC
Arthritis Rheum; 1995 Oct; 38(10):1418-28. PubMed ID: 7575692
[TBL] [Abstract][Full Text] [Related]
26. Optimization of high-throughput autoantibody profiling for the discovery of novel antigenic targets in rheumatoid arthritis.
Somers K; Stinissen P; Somers V
Ann N Y Acad Sci; 2009 Sep; 1173():92-102. PubMed ID: 19758137
[TBL] [Abstract][Full Text] [Related]
27. New autoantibodies in early rheumatoid arthritis.
Charpin C; Arnoux F; Martin M; Toussirot E; Lambert N; Balandraud N; Wendling D; Diot E; Roudier J; Auger I
Arthritis Res Ther; 2013 Jul; 15(4):R78. PubMed ID: 23886014
[TBL] [Abstract][Full Text] [Related]
28. Novel autoantibody markers for early and seronegative rheumatoid arthritis.
Somers K; Geusens P; Elewaut D; De Keyser F; Rummens JL; Coenen M; Blom M; Stinissen P; Somers V
J Autoimmun; 2011 Feb; 36(1):33-46. PubMed ID: 21071175
[TBL] [Abstract][Full Text] [Related]
29. The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis.
Simon M; Girbal E; Sebbag M; Gomès-Daudrix V; Vincent C; Salama G; Serre G
J Clin Invest; 1993 Sep; 92(3):1387-93. PubMed ID: 7690781
[TBL] [Abstract][Full Text] [Related]
30. Anti-Fc gamma receptor III autoantibody is associated with soluble receptor in rheumatoid arthritis serum and synovial fluid.
Lamour A; Baron D; Soubrane C; Cartron J; Khayat D; Adler Y; Le Goff P; Youinou P
J Autoimmun; 1995 Apr; 8(2):249-65. PubMed ID: 7612151
[TBL] [Abstract][Full Text] [Related]
31. HLA-DRB1*0404 is strongly associated with anticalpastatin antibodies in rheumatoid arthritis.
Auger I; Roudier C; Guis S; Balandraud N; Roudier J
Ann Rheum Dis; 2007 Dec; 66(12):1588-93. PubMed ID: 17324966
[TBL] [Abstract][Full Text] [Related]
32. Characterization of two corneal epithelium-derived antigens associated with vasculitis.
Reynolds I; John SL; Tullo AB; Ayad S; Morgan K; Ballardie FW; Holt PJ; Hillarby MC
Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2594-601. PubMed ID: 9856769
[TBL] [Abstract][Full Text] [Related]
33. Human monoclonal rheumatoid synovial B lymphocyte hybridoma with a new disease-related specificity for cartilage oligomeric matrix protein.
Souto-Carneiro MM; Burkhardt H; Müller EC; Hermann R; Otto A; Kraetsch HG; Sack U; König A; Heinegård D; Müller-Hermelink HK; Krenn V
J Immunol; 2001 Mar; 166(6):4202-8. PubMed ID: 11238672
[TBL] [Abstract][Full Text] [Related]
34. Autoantibodies to PAD4 and BRAF in rheumatoid arthritis.
Auger I; Charpin C; Balandraud N; Martin M; Roudier J
Autoimmun Rev; 2012 Sep; 11(11):801-3. PubMed ID: 22349616
[TBL] [Abstract][Full Text] [Related]
35. Anti-carbonic anhydrase III autoantibodies in vasculitis syndrome.
Saito R; Watanabe H; Asano T; Suzuki E; Iwadate H; Kobayashi H; Ohira H
Int J Rheum Dis; 2013 Jun; 16(3):339-46. PubMed ID: 23981757
[TBL] [Abstract][Full Text] [Related]
36. Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells.
Joshua V; Schobers L; Titcombe PJ; Israelsson L; Rönnelid J; Hansson M; Catrina AI; Pruijn GJ; Malmström V
Arthritis Res Ther; 2016 Dec; 18(1):284. PubMed ID: 27906052
[TBL] [Abstract][Full Text] [Related]
37. Anti-MBL autoantibodies in patients with rheumatoid arthritis: prevalence and clinical significance.
Gupta B; Raghav SK; Agrawal C; Chaturvedi VP; Das RH; Das HR
J Autoimmun; 2006 Sep; 27(2):125-33. PubMed ID: 16904869
[TBL] [Abstract][Full Text] [Related]
38. New autoantigens in rheumatoid arthritis (RA): screening 8268 protein arrays with sera from patients with RA.
Auger I; Balandraud N; Rak J; Lambert N; Martin M; Roudier J
Ann Rheum Dis; 2009 Apr; 68(4):591-4. PubMed ID: 18957483
[TBL] [Abstract][Full Text] [Related]
39. Antibodies to native and citrullinated RA33 (hnRNP A2/B1) challenge citrullination as the inciting principle underlying loss of tolerance in rheumatoid arthritis.
Konig MF; Giles JT; Nigrovic PA; Andrade F
Ann Rheum Dis; 2016 Nov; 75(11):2022-2028. PubMed ID: 26865600
[TBL] [Abstract][Full Text] [Related]
40. Sensitivity and specificity of anti-Sa autoantibodies for rheumatoid arthritis.
Hueber W; Hassfeld W; Smolen JS; Steiner G
Rheumatology (Oxford); 1999 Feb; 38(2):155-9. PubMed ID: 10342629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
